The Effect of Medicare's Chemotherapy Payment Cuts on Rituximab Use and Survival Outcomes

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.753
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Impact of Medicare's Alternative Payment Models on the Value of Care

Annual Review of Public Health
MedicineEnvironmentalPublic HealthOccupational Health
2020English

Medicare's New Quality Payment Program Has Started—Are You Ready?

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2017English

Effect of Dividend Payment on the Earnings Quality

2019English

Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Real-World Effect of Maintenance and Intermittent Chemotherapy on Survival in Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

A Preliminary Analysis of Beneficiary Discharge Status and Post-Hospital Placement Before and After the Implementation of Medicare's Prospective Payment System

2000English

Evidence and Medicare's Coverage of Interventions

Health Affairs
MedicineHealth Policy
2015English

P1.12-09 the Effect of Site of First Chemotherapy on Small Cell Lung Cancer Patient Outcomes

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effects of Payment Timing and Prior Outcomes on the Composition of Choices Over Public Lotteries

Theoretical Economics Letters
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy